SMART Bun-Yo-Matic CT
Disior Ltd • Radiology • 06/20/2024
Device Purpose
The SMART Bun-Yo-Matic CT software provides orthopedic professionals with an advanced tool for diagnosing and planning foot and ankle surgeries, particularly Lapidus Arthrodesis for hallux valgus, by leveraging machine learning to automatically segment anatomical structures from CT scans and generate detailed 3D models and quantitative measurements. Its methodology involves processing CT DICOM images to create patient-specific visualizations, including implant constructs and surgical instrument parameters, validated through rigorous testing on diverse datasets to ensure accuracy in segmentation and measurements for pre-operative decision-making.
Summary
The SMART Bun-Yo-Matic CT is a software tool designed for orthopedic healthcare professionals to aid in the diagnosis and surgical planning of foot and ankle conditions, specifically targeting hallux valgus correction via Lapidus Arthrodesis. It utilizes Computed Tomography (CT) scans as input to automatically segment bones of the foot and ankle. The software then generates a comprehensive case report which includes three-dimensional (3D) models of the patient's anatomy, pre-operative measurements, and visualizations of post-correction anatomy. Additionally, it provides parameters for orthopedic surgical instruments and an example of an implant construct, facilitating detailed pre-surgical planning. The core of the SMART Bun-Yo-Matic CT's functionality relies on machine learning algorithms for bone segmentation and metal identification. These algorithms were developed and validated using a diverse dataset of 357 CT image studies from various imaging systems, patient demographics, and clinical conditions, including a minimum of 50% US-sourced images. Ground truth for validation was established by a consensus of three orthopedic surgeons. Performance testing on 82 CT image series demonstrated 100% accuracy in identifying foot and ankle bones and 98.8% accuracy for metal identification (98% specificity, 100% sensitivity). Further software verification and validation confirmed model conformance within 1.0mm and angular measurement accuracy within specified tolerances for surgical planning.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the software's performance in segmenting bones and identifying metal vary across different CT scanner manufacturers and imaging protocols, beyond the reported aggregate statistics?; What specific machine learning model architectures are employed for bone segmentation and metal detection, and how were they optimized for complex anatomical variations or the presence of artifacts?; Can the surgical planning module adapt to different surgical techniques for Lapidus Arthrodesis or other foot/ankle procedures beyond what is explicitly stated for hallux valgus?; How does the accuracy of the software's automated measurements (e.g., intermetatarsal angle, hallux valgus angle) compare to manual measurements performed by experienced orthopedic surgeons, and what is the inter-observer variability of the software?; What is the typical processing time for a complete case, from CT image input to the generation of the final visualization report and surgical plan, in a clinical setting?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly